Aptar Pharma introduces PureHale respiratory drug delivery solution
Aptar Pharma has introduced a new portable and ready-to-use drug delivery solution, dubbed PureHale, for upper respiratory care.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Oct 18
Aptar Pharma has introduced a new portable and ready-to-use drug delivery solution, dubbed PureHale, for upper respiratory care.
28 Sep 18
Marizyme, a development-stage company dedicated to commercialize therapies in the acute care space, has acquired protease drug platform.
25 Sep 18
Cook Medical has secured approval from the US Food and Drug Administration (FDA) for the new 5mm diameter…
05 Sep 18
The Japanese Patent Office has issued a Decision to Grant a patent covering Absorption Systems' In Vitro Dissolution…
30 Aug 18
Otsuka America Pharmaceutical (Otsuka) has signed a collaboration agreement to facilitate access to the ABILIFY MYCITE system to…
22 Aug 18
Ichor Medical Systems said that its investigational TriGrid delivery system is being used in a clinical study to…
21 Aug 18
Healthcare technology firm RDMD has secured $3m seed funding to further develop its technology platform, which generates deep…
16 Aug 18
Limerick, PA. August 9, 2018 – Rockland Immunochemicals, Inc. announced today that Dr. Carl Ascoli, Chief Science Officer…